GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » YoY Rev. per Sh. Growth

Remus Pharmaceuticals (NSE:REMUS) YoY Rev. per Sh. Growth : 767.10% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Remus Pharmaceuticals's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was 767.10%.

Remus Pharmaceuticals's Revenue per Share for the six months ended in Sep. 2024 was ₹462.81.

Remus Pharmaceuticals YoY Rev. per Sh. Growth Historical Data

The historical data trend for Remus Pharmaceuticals's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals YoY Rev. per Sh. Growth Chart

Remus Pharmaceuticals Annual Data
Trend Mar20 Mar21 Mar22 Mar24
YoY Rev. per Sh. Growth
- 54.53 34.20 793.71

Remus Pharmaceuticals Semi-Annual Data
Mar20 Mar21 Mar22 Sep23 Mar24 Sep24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial - - - - 767.10

Remus Pharmaceuticals YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Remus Pharmaceuticals's YoY Rev. per Sh. Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Mar. 2024 )
=(Revenue per Share (A: Mar. 2024 )-Revenue per Share (A: Mar. 2022 ))/ | Revenue per Share (A: Mar. 2022 ) |
=(374.911-41.95)/ | 41.95 |
=793.71 %

Remus Pharmaceuticals's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=(Revenue per Share (Q: Sep. 2024 )-Revenue per Share (Q: Sep. 2023 )) / | Revenue per Share (Q: Sep. 2023 )) |
=(462.805-53.374)/ | 53.374 |
=767.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Remus Pharmaceuticals YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Remus Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
NSE:DENTALKART BOM:544143 BOM:530697 BOM:536565 BOM:543500 BOM:523896 BOM:531240 NSE:ENTERO MCK COR CAH SHSE:601607 HSIC HKSE:01099 SHSE:600332 MIL:AMP NZSE:EBO XSWX:GALE SHSE:600511 TSE:7459
Traded in Other Exchanges
N/A
Address
Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054
Website
https://www.remuspharma.com
Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines